These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 2119931)
1. The successful treatment of idiopathic thrombocytopenic purpura with the low dose non specific IgG component of anti D immunoglobulin. Smith NA; Chakraverty RK; Boughton BJ Clin Lab Haematol; 1990; 12(2):131-6. PubMed ID: 2119931 [TBL] [Abstract][Full Text] [Related]
2. [Use of anti-D (Rh) IgG or intramuscular polyvalent human immunoglobulin in the treatment of chronic autoimmune thrombocytopenic purpura]. Vizcaíno G; Diez-Ewald M; Arteaga-Vizcaíno M; Torres E Invest Clin; 1992; 33(4):165-74. PubMed ID: 1338940 [TBL] [Abstract][Full Text] [Related]
3. Transient reversal of thrombocytopenia in idiopathic thrombocytopenic purpura by high-dose intravenous gamma globulin. Fehr J; Hofmann V; Kappeler U N Engl J Med; 1982 May; 306(21):1254-8. PubMed ID: 6803159 [TBL] [Abstract][Full Text] [Related]
5. Rhesus antibody treatment for idiopathic thrombocytopenic purpura in an Rh-negative patient. Rossi E; Damasio EE; Cerri R; Sogno G; Lercari G; Incagliato M; Marmont A Haematologica; 1988; 73(6):521-3. PubMed ID: 3148517 [No Abstract] [Full Text] [Related]
6. [Rhesus(D)-IgG-antibodies in the treatment of autoimmune thrombocytopenia]. Giers G; Salama A; Mueller-Eckhardt C Dtsch Med Wochenschr; 1992 Jan; 117(1):1-5. PubMed ID: 1730192 [TBL] [Abstract][Full Text] [Related]
7. Intravenous plasmin-treated gammaglobulin therapy in idiopathic thrombocytopenic purpura. Results in 40 patients. Follea G; Souillet G; Clerc M; Philippe N; Bordet JC; Dechavanne M Nouv Rev Fr Hematol (1978); 1985; 27(1):5-10. PubMed ID: 3157922 [TBL] [Abstract][Full Text] [Related]
8. High dose intravenous IgG followed by splenectomy versus splenectomy alone in idiopathic thrombocytopenic purpura refractory to steroids. Lang JM; Amaral D; Audhuy B; Barats JC; Boilletot A; Oberling F Nouv Rev Fr Hematol (1978); 1987; 29(5):285-7. PubMed ID: 3438162 [TBL] [Abstract][Full Text] [Related]
9. Enhanced efficacy of anti-D immunoglobulin for treating ITP is not explained by higher immunoglobulin polymer content. Dolman C; Thorpe SJ; Thorpe R Biologicals; 2001 Jun; 29(2):75-9. PubMed ID: 11580212 [TBL] [Abstract][Full Text] [Related]
10. A randomized and comparative study of intravenous immunoglobulin and mega dose methylprednisolone treatments in children with acute idiopathic thrombocytopenic purpura. Erduran E; Aslan Y; Gedik Y; Orhan F Turk J Pediatr; 2003; 45(4):295-300. PubMed ID: 14768792 [TBL] [Abstract][Full Text] [Related]
11. Efficacy, safety, and dose response of intravenous anti-D immune globulin (WinRho SDF) for the treatment of idiopathic thrombocytopenic purpura in children. Freiberg A; Mauger D Semin Hematol; 1998 Jan; 35(1 Suppl 1):23-7. PubMed ID: 9523746 [TBL] [Abstract][Full Text] [Related]
12. First-line therapies for immune thrombocytopenic purpura: re-evaluating the need to treat. Rodeghiero F Eur J Haematol Suppl; 2008 Feb; (69):19-26. PubMed ID: 18211569 [TBL] [Abstract][Full Text] [Related]
13. [Treatment of idiopathic thrombocytopenic purpura and thrombocytopenia associated with the HIV virus using anti-Rhesus immunoglobulins]. Durand JM; Lefèvre P; Lafforgue P; Harlé JR; Quinsat D; Mongin M Presse Med; 1989 Feb; 18(4):161-4. PubMed ID: 2522199 [TBL] [Abstract][Full Text] [Related]
14. Intramuscular anti-D immunoglobulins for home treatment of chronic immune thrombocytopenic purpura. Gringeri A; Cattaneo M; Santagostino E; Mannucci PM Br J Haematol; 1992 Mar; 80(3):337-40. PubMed ID: 1581213 [TBL] [Abstract][Full Text] [Related]
15. Efficacy and response to intravenous anti-D immunoglobulin in chronic idiopathic thrombocytopenic purpura. Ramadan KM; El-Agnaf M Clin Lab Haematol; 2005 Aug; 27(4):267-9. PubMed ID: 16048495 [TBL] [Abstract][Full Text] [Related]
16. In vivo and in vitro blocking of human lymphocyte Fc gamma-receptors by intravenous gammaglobulin. Sandilands GP; Atrah HI; Templeton G; Cocker JE; Lucie N; Crawford RJ; MacSween RN J Clin Lab Immunol; 1987 Jul; 23(3):109-15. PubMed ID: 2959781 [TBL] [Abstract][Full Text] [Related]
17. Immunoglobulin bound to platelets as immune complexes or specific antibody in specimens from acquired immunodeficiency syndrome and immune thrombocytopenic purpura. Daugharty H; Chorba TL; Personette DW; Savoca KV; MacDonald V Diagn Immunol; 1985; 3(4):205-14. PubMed ID: 2935354 [TBL] [Abstract][Full Text] [Related]
18. Anti-D immunoglobulin in children with newly diagnosed immune thrombocytopenic purpura: a pilot study. Monteleone PM; Vander Heyden MA; Steele DA; Kelleher JF Haematologica; 2000 Aug; 85(8):887-8. PubMed ID: 10942950 [No Abstract] [Full Text] [Related]
19. The effect of anti-Rho(D) and non-specific immunoglobulins on monocyte Fc receptor function: the role of high molecular weight IgG polymers and IgG subclasses. Boughton BJ; Chakraverty RK; Simpson A; Smith N Clin Lab Haematol; 1990; 12(1):17-23. PubMed ID: 2160875 [TBL] [Abstract][Full Text] [Related]
20. Clinical effect and some pathogenic mechanisms of high dose monomeric IgG therapy in childhood chronic idiopathic thrombocytopenic purpura. Koshel IV; Torubarova NA; Omarova KO; Kurmashov VI Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(3):365-72. PubMed ID: 2428711 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]